| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUACCUUUCCCAGCAGAGCACCUGGGUUGGUCCCGAAGCCUCCAACCAC… | 1577 nt | 0.5460 | |
| CUACCUUUCCCAGCAGAGCACCUGGGUUGGUCCCGAAGCCUCCAACCAC… | 1571 nt | 0.5455 | |
| CUACCUUUCCCAGCAGAGCACCUGGGUUGGUCCCGAAGCCUCCAACCAC… | 1490 nt | 0.5483 | |
| CUACCUUUCCCAGCAGAGCACCUGGGUUGGUCCCGAAGCCUCCAACCAC… | 1574 nt | 0.5457 |
The protein encoded by this gene is a negatively-charged serum glycoprotein that is synthesized by hepatocytes. The encoded protein consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several processes, including endocytosis, brain development, and the formation of bone tissue. Defects in this gene are a cause of susceptibility to leanness. [provided by RefSeq, Aug 2017]
The protein marker AHSG is identified as a biomarker for post-mortem interval (PMI) estimation in bone, where it shows a loss in abundance over time following death [Alex et al. DOI:10.1016/j.scijus.2025.101320]. A study in human blood plasma demonstrated that the AHSG (Alpha-2-HS-glycoprotein) was significantly downregulated with age [Salignon et al. DOI:10.18632/aging.204787].